Regulatory Roundup: Top News Stories – Week Ending June 16, 2017

This week the FDA granted Breakthrough Therapy designation to multiple programs, granted an Orphan Drug designation and also rejected a biosimilar application.  Here is a summary of the top 10 regulatory stories to follow this week: Proteon Therapeutics received FDA Breakthrough Therapy Designation for Vonapanitase for chronic kidney disease. Full Story Here The FDA’s Oncologic[…]